Omega Protein
OME
OME was delisted on the 19th of December, 2017.
140 hedge funds and large institutions have $353M invested in Omega Protein in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 19 closing their positions.
93% more call options, than puts
Call options by funds: $653K | Put options by funds: $338K
15% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 46
3% less funds holding
Funds holding: 144 → 140 (-4)
11% less capital invested
Capital invested by funds: $396M → $353M (-$43M)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.4M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$5.32M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$2.48M |
| 4 |
FM
Fondren Management
Houston,
Texas
|
+$1.29M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JIR
James Investment Research
Alpha,
Ohio
|
-$9.1M |
| 2 |
Millennium Management
New York
|
-$3.13M |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$2.9M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.86M |
| 5 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
-$1.49M |
OME Hedge Fund Activity: Q2 2017 in Review
140 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Omega Protein (OME) for Q2 2017, worth a combined $353M — down 11% from $396M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of OME and 16 opened new positions — a net loss of 3 holders — while 46 trimmed existing stakes and 53 added.
The largest buyer was Fidelity Investments, adding an estimated $13.4M. The largest seller was James Investment Research, cutting an estimated $9.1M.
- 140 institutional investors held Omega Protein (OME) as of Q2 2017, down from 144 in Q1 2017.
- Funds reported $353M of Omega Protein stock for Q2 2017, down 11% quarter-over-quarter.
- 16 funds opened new Omega Protein positions in Q2 2017 and 19 closed out, a net change of -3 holders.
- The largest Omega Protein buyer in Q2 2017 was Fidelity Investments, an estimated $13.4M added.
- The largest Omega Protein seller in Q2 2017 was James Investment Research, an estimated $9.1M sold.
Based on aggregated 13F filings for Q2 2017.